The Neuronet programme actively connects 18 research projects, encompassing EUR 386 million of funding. All of these projects have been launched by the Innovative Medicines Initiative, Europe's biggest public and private partnership in the life sciences.
To enhance the visibility of the Innovative Medicines Initiative neurodegeneration programme, Neuronet publishes a quarterly newsletter, providing readers with updates and a snapshot of the biggest achievements within the programme so far. Click on the images below to access the newsletter issues published to date, or click here to subscribe.
Spotlight on early-career investigators: a Neuronet interview with Clint Hansen (Mobilise-D)
Neuronet launches Knowledge Base
The final EPAD dataset is now available to the entire research community
RADAR-CNS Epilepsy Study 2 begins recruitment
Presentations from annual Neuronet event at the Alzheimer Europe conference are now online
Spotlight on early career investigators: Alpha Tom Kodamullil (AETIONOMY)
Neuronet holds successful Scientific Coordination Board Meeting
AMYPAD Prognostic and Natural History Study reaches milestone of 500 research participants
Alzheimer Europe & Neuronet team up to hold European Parliament lunch debate on the IMI and dementia research
Spotlight on early career investigators: Benjamin Falcon (IMPRIND)
Neuronet convenes a Scientific Coordination Board meeting
ROADMAP releases a 3D tool showing the landscape of European data available for Alzheimer's disease research
PRISM publishes a series of reviews in Neuroscience & Biobehavioural review
Subscribe to our mailing list